Novel Approaches to Risk Assessment for Ventricular Tachycardia Induction and Therapy View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2021-01-11

AUTHORS

Yuki Ishidoya, Ravi Ranjan

ABSTRACT

Purpose of ReviewVentricular tachycardia (VT) is a significant cause of cardiac sudden death (SCD) in various cardiomyopathy diseases. The following review will focus on the role of cardiac imaging in risk assessment for VT induction and novel technique and evidence regarding VT therapy including VT ablation and implantable cardiac defibrillator (ICD) therapy.Recent FindingsIn regard to VT risk stratification, characterizing VT substrate by cardiac imaging including cardiac magnetic resonance (CMR), multidetector computed tomography (MDCT), and positron-emission tomography (PET) has a significant role in predicting mortality and ventricular arrhythmic events. Integrating cardiac imaging with electroanatomic mapping can act synergistically on improving VT ablation. Moreover, recently developed novel ablation technologies such as bipolar ablation (BPA) and stereotactic body radiotherapy (SBRT) can be potentially beneficial to patients with VTs that are not responding to conventional treatment strategies. Besides, the effectiveness of novel concept of antitachycardia pacing (ATP), automated ATP, has been reported by using virtual patient modeling recently.SummaryRisk stratification for future VT episodes is significantly important to timely select ICD candidates for patients with cardiomyopathy, and cardiac imaging can play a distinct role in this process. Novel and less invasive VT mapping, ablation techniques, and newly developed adaptive pacing techniques can help us overcome challenging VT cases and further improve the treatment for these life-threatening arrhythmias including prevention of sudden death. More... »

PAGES

4

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s12170-020-00666-0

DOI

http://dx.doi.org/10.1007/s12170-020-00666-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1134500685


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Nora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, Salt Lake City, UT, USA", 
          "id": "http://www.grid.ac/institutes/grid.223827.e", 
          "name": [
            "Division of Cardiovascular Medicine, University of Utah, 30 N 1900 E Rm 4A100, 84132-2101, Salt Lake City, UT, USA", 
            "Nora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, Salt Lake City, UT, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ishidoya", 
        "givenName": "Yuki", 
        "id": "sg:person.015332120557.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015332120557.28"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Biomedical Engineering, University of Utah, Salt Lake City, UT, USA", 
          "id": "http://www.grid.ac/institutes/grid.223827.e", 
          "name": [
            "Division of Cardiovascular Medicine, University of Utah, 30 N 1900 E Rm 4A100, 84132-2101, Salt Lake City, UT, USA", 
            "Nora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, Salt Lake City, UT, USA", 
            "Biomedical Engineering, University of Utah, Salt Lake City, UT, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ranjan", 
        "givenName": "Ravi", 
        "id": "sg:person.01211344506.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01211344506.35"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00330-017-4869-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1086035776", 
          "https://doi.org/10.1007/s00330-017-4869-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1532-429x-15-92", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009837447", 
          "https://doi.org/10.1186/1532-429x-15-92"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12968-016-0308-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017591814", 
          "https://doi.org/10.1186/s12968-016-0308-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11604-006-0113-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041184909", 
          "https://doi.org/10.1007/s11604-006-0113-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/s41569-018-0104-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1107818909", 
          "https://doi.org/10.1038/s41569-018-0104-y"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2021-01-11", 
    "datePublishedReg": "2021-01-11", 
    "description": "Purpose of ReviewVentricular tachycardia (VT) is a significant cause of cardiac sudden death (SCD) in various cardiomyopathy diseases. The following review will focus on the role of cardiac imaging in risk assessment for VT induction and novel technique and evidence regarding VT therapy including VT ablation and implantable cardiac defibrillator (ICD) therapy.Recent FindingsIn regard to VT risk stratification, characterizing VT substrate by cardiac imaging including cardiac magnetic resonance (CMR), multidetector computed tomography (MDCT), and positron-emission tomography (PET) has a significant role in predicting mortality and ventricular arrhythmic events. Integrating cardiac imaging with electroanatomic mapping can act synergistically on improving VT ablation. Moreover, recently developed novel ablation technologies such as bipolar ablation (BPA) and stereotactic body radiotherapy (SBRT) can be potentially beneficial to patients with VTs that are not responding to conventional treatment strategies. Besides, the effectiveness of novel concept of antitachycardia pacing (ATP), automated ATP, has been reported by using virtual patient modeling recently.SummaryRisk stratification for future VT episodes is significantly important to timely select ICD candidates for patients with cardiomyopathy, and cardiac imaging can play a distinct role in this process. Novel and less invasive VT mapping, ablation techniques, and newly developed adaptive pacing techniques can help us overcome challenging VT cases and further improve the treatment for these life-threatening arrhythmias including prevention of sudden death.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s12170-020-00666-0", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1039476", 
        "issn": [
          "1932-9520", 
          "1932-9563"
        ], 
        "name": "Current Cardiovascular Risk Reports", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "15"
      }
    ], 
    "keywords": [
      "stereotactic body radiotherapy", 
      "cardiac magnetic resonance", 
      "positron emission tomography", 
      "VT ablation", 
      "cardiac imaging", 
      "sudden death", 
      "implantable cardiac defibrillator therapy", 
      "VT risk stratification", 
      "novel ablation technology", 
      "ventricular tachycardia induction", 
      "bipolar ablation", 
      "ventricular arrhythmic events", 
      "cardiac sudden death", 
      "life-threatening arrhythmias", 
      "conventional treatment strategies", 
      "tachycardia induction", 
      "defibrillator therapy", 
      "risk stratification", 
      "body radiotherapy", 
      "VT therapy", 
      "VT induction", 
      "arrhythmic events", 
      "ICD candidates", 
      "electroanatomic mapping", 
      "VT episodes", 
      "treatment strategies", 
      "VT substrate", 
      "VT mapping", 
      "virtual patient modeling", 
      "pacing techniques", 
      "significant cause", 
      "VT cases", 
      "therapy", 
      "cardiomyopathy disease", 
      "ablation technology", 
      "patients", 
      "ablation technique", 
      "ablation", 
      "death", 
      "tomography", 
      "imaging", 
      "magnetic resonance", 
      "induction", 
      "distinct roles", 
      "patient modeling", 
      "tachycardia", 
      "risk assessment", 
      "radiotherapy", 
      "antitachycardia", 
      "arrhythmias", 
      "multidetector", 
      "stratification", 
      "mortality", 
      "disease", 
      "prevention", 
      "role", 
      "assessment", 
      "episodes", 
      "treatment", 
      "cause", 
      "VT", 
      "significant role", 
      "review", 
      "evidence", 
      "ATP", 
      "cases", 
      "novel technique", 
      "events", 
      "regard", 
      "candidates", 
      "purpose", 
      "novel approach", 
      "technique", 
      "strategies", 
      "effectiveness", 
      "novel concept", 
      "resonance", 
      "mapping", 
      "approach", 
      "process", 
      "substrate", 
      "concept", 
      "technology", 
      "modeling"
    ], 
    "name": "Novel Approaches to Risk Assessment for Ventricular Tachycardia Induction and Therapy", 
    "pagination": "4", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1134500685"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s12170-020-00666-0"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s12170-020-00666-0", 
      "https://app.dimensions.ai/details/publication/pub.1134500685"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-20T07:39", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_905.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s12170-020-00666-0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s12170-020-00666-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s12170-020-00666-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s12170-020-00666-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s12170-020-00666-0'


 

This table displays all metadata directly associated to this object as RDF triples.

176 TRIPLES      22 PREDICATES      115 URIs      101 LITERALS      6 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s12170-020-00666-0 schema:about anzsrc-for:11
2 anzsrc-for:1102
3 anzsrc-for:1103
4 schema:author N28d1c37a4c2d4e24aece50aecc04eed8
5 schema:citation sg:pub.10.1007/s00330-017-4869-x
6 sg:pub.10.1007/s11604-006-0113-3
7 sg:pub.10.1038/s41569-018-0104-y
8 sg:pub.10.1186/1532-429x-15-92
9 sg:pub.10.1186/s12968-016-0308-4
10 schema:datePublished 2021-01-11
11 schema:datePublishedReg 2021-01-11
12 schema:description Purpose of ReviewVentricular tachycardia (VT) is a significant cause of cardiac sudden death (SCD) in various cardiomyopathy diseases. The following review will focus on the role of cardiac imaging in risk assessment for VT induction and novel technique and evidence regarding VT therapy including VT ablation and implantable cardiac defibrillator (ICD) therapy.Recent FindingsIn regard to VT risk stratification, characterizing VT substrate by cardiac imaging including cardiac magnetic resonance (CMR), multidetector computed tomography (MDCT), and positron-emission tomography (PET) has a significant role in predicting mortality and ventricular arrhythmic events. Integrating cardiac imaging with electroanatomic mapping can act synergistically on improving VT ablation. Moreover, recently developed novel ablation technologies such as bipolar ablation (BPA) and stereotactic body radiotherapy (SBRT) can be potentially beneficial to patients with VTs that are not responding to conventional treatment strategies. Besides, the effectiveness of novel concept of antitachycardia pacing (ATP), automated ATP, has been reported by using virtual patient modeling recently.SummaryRisk stratification for future VT episodes is significantly important to timely select ICD candidates for patients with cardiomyopathy, and cardiac imaging can play a distinct role in this process. Novel and less invasive VT mapping, ablation techniques, and newly developed adaptive pacing techniques can help us overcome challenging VT cases and further improve the treatment for these life-threatening arrhythmias including prevention of sudden death.
13 schema:genre article
14 schema:inLanguage en
15 schema:isAccessibleForFree false
16 schema:isPartOf N9accb5836ab5481b94ef179df2c036ff
17 Nb952d9d434954428816eea14568b8139
18 sg:journal.1039476
19 schema:keywords ATP
20 ICD candidates
21 VT
22 VT ablation
23 VT cases
24 VT episodes
25 VT induction
26 VT mapping
27 VT risk stratification
28 VT substrate
29 VT therapy
30 ablation
31 ablation technique
32 ablation technology
33 antitachycardia
34 approach
35 arrhythmias
36 arrhythmic events
37 assessment
38 bipolar ablation
39 body radiotherapy
40 candidates
41 cardiac imaging
42 cardiac magnetic resonance
43 cardiac sudden death
44 cardiomyopathy disease
45 cases
46 cause
47 concept
48 conventional treatment strategies
49 death
50 defibrillator therapy
51 disease
52 distinct roles
53 effectiveness
54 electroanatomic mapping
55 episodes
56 events
57 evidence
58 imaging
59 implantable cardiac defibrillator therapy
60 induction
61 life-threatening arrhythmias
62 magnetic resonance
63 mapping
64 modeling
65 mortality
66 multidetector
67 novel ablation technology
68 novel approach
69 novel concept
70 novel technique
71 pacing techniques
72 patient modeling
73 patients
74 positron emission tomography
75 prevention
76 process
77 purpose
78 radiotherapy
79 regard
80 resonance
81 review
82 risk assessment
83 risk stratification
84 role
85 significant cause
86 significant role
87 stereotactic body radiotherapy
88 strategies
89 stratification
90 substrate
91 sudden death
92 tachycardia
93 tachycardia induction
94 technique
95 technology
96 therapy
97 tomography
98 treatment
99 treatment strategies
100 ventricular arrhythmic events
101 ventricular tachycardia induction
102 virtual patient modeling
103 schema:name Novel Approaches to Risk Assessment for Ventricular Tachycardia Induction and Therapy
104 schema:pagination 4
105 schema:productId Nc7849409beb94dbab9a0516b3d6782a5
106 Nc936ff4f765a4709a995f2e26f53c4cc
107 schema:sameAs https://app.dimensions.ai/details/publication/pub.1134500685
108 https://doi.org/10.1007/s12170-020-00666-0
109 schema:sdDatePublished 2022-05-20T07:39
110 schema:sdLicense https://scigraph.springernature.com/explorer/license/
111 schema:sdPublisher Nbfd59d13f6c04281b7046dbcda8a0a56
112 schema:url https://doi.org/10.1007/s12170-020-00666-0
113 sgo:license sg:explorer/license/
114 sgo:sdDataset articles
115 rdf:type schema:ScholarlyArticle
116 N1dce1fbfcc6d40e9a3cd88a4577773ad rdf:first sg:person.01211344506.35
117 rdf:rest rdf:nil
118 N28d1c37a4c2d4e24aece50aecc04eed8 rdf:first sg:person.015332120557.28
119 rdf:rest N1dce1fbfcc6d40e9a3cd88a4577773ad
120 N9accb5836ab5481b94ef179df2c036ff schema:volumeNumber 15
121 rdf:type schema:PublicationVolume
122 Nb952d9d434954428816eea14568b8139 schema:issueNumber 2
123 rdf:type schema:PublicationIssue
124 Nbfd59d13f6c04281b7046dbcda8a0a56 schema:name Springer Nature - SN SciGraph project
125 rdf:type schema:Organization
126 Nc7849409beb94dbab9a0516b3d6782a5 schema:name dimensions_id
127 schema:value pub.1134500685
128 rdf:type schema:PropertyValue
129 Nc936ff4f765a4709a995f2e26f53c4cc schema:name doi
130 schema:value 10.1007/s12170-020-00666-0
131 rdf:type schema:PropertyValue
132 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
133 schema:name Medical and Health Sciences
134 rdf:type schema:DefinedTerm
135 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
136 schema:name Cardiorespiratory Medicine and Haematology
137 rdf:type schema:DefinedTerm
138 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
139 schema:name Clinical Sciences
140 rdf:type schema:DefinedTerm
141 sg:journal.1039476 schema:issn 1932-9520
142 1932-9563
143 schema:name Current Cardiovascular Risk Reports
144 schema:publisher Springer Nature
145 rdf:type schema:Periodical
146 sg:person.01211344506.35 schema:affiliation grid-institutes:grid.223827.e
147 schema:familyName Ranjan
148 schema:givenName Ravi
149 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01211344506.35
150 rdf:type schema:Person
151 sg:person.015332120557.28 schema:affiliation grid-institutes:grid.223827.e
152 schema:familyName Ishidoya
153 schema:givenName Yuki
154 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015332120557.28
155 rdf:type schema:Person
156 sg:pub.10.1007/s00330-017-4869-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1086035776
157 https://doi.org/10.1007/s00330-017-4869-x
158 rdf:type schema:CreativeWork
159 sg:pub.10.1007/s11604-006-0113-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041184909
160 https://doi.org/10.1007/s11604-006-0113-3
161 rdf:type schema:CreativeWork
162 sg:pub.10.1038/s41569-018-0104-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1107818909
163 https://doi.org/10.1038/s41569-018-0104-y
164 rdf:type schema:CreativeWork
165 sg:pub.10.1186/1532-429x-15-92 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009837447
166 https://doi.org/10.1186/1532-429x-15-92
167 rdf:type schema:CreativeWork
168 sg:pub.10.1186/s12968-016-0308-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017591814
169 https://doi.org/10.1186/s12968-016-0308-4
170 rdf:type schema:CreativeWork
171 grid-institutes:grid.223827.e schema:alternateName Biomedical Engineering, University of Utah, Salt Lake City, UT, USA
172 Nora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, Salt Lake City, UT, USA
173 schema:name Biomedical Engineering, University of Utah, Salt Lake City, UT, USA
174 Division of Cardiovascular Medicine, University of Utah, 30 N 1900 E Rm 4A100, 84132-2101, Salt Lake City, UT, USA
175 Nora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, Salt Lake City, UT, USA
176 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...